NewcelX partners with Eledon to develop diabetes treatment
Go back to NewcelX partners with Eledon to develop diabetes treatment| (NASDAQ: ELDN) | Delayed: 3.02 +0.04 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.98 | 52 Week High | $ | |||
| Open | $2.93 | 52 Week Low | $ | |||
| Day High | $3.02 | P/E | N/A | |||
| Day Low | $2.89 | EPS | $ | |||
| Volume | 535,197 | |||||
| (NASDAQ: NCEL) | Delayed: 3.26 -0.01 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.27 | 52 Week High | $ | |||
| Open | $3.21 | 52 Week Low | $ | |||
| Day High | $3.26 | P/E | N/A | |||
| Day Low | $3.21 | EPS | $ | |||
| Volume | 1,113 | |||||
